-
MRSN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Mersana Therapeutics (MRSN)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 79.35 mm | 79.35 mm | 79.35 mm | 79.35 mm | 79.35 mm | |
Cash burn (monthly) | (no burn) | 4.16 mm | 3.69 mm | 9.59 mm | 9.23 mm | |
Cash used (since last report) | n/a | 11.64 mm | 10.35 mm | 26.88 mm | 25.85 mm | |
Cash remaining | n/a | 67.70 mm | 69.00 mm | 52.47 mm | 53.50 mm | |
Runway (months of cash) | n/a | 16.3 | 18.7 | 5.5 | 5.8 |
13F holders | Current |
---|---|
Total holders | 119 |
Opened positions | 13 |
Closed positions | 21 |
Increased positions | 38 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 217.37 bn |
Total shares | 150.30 mm |
Total puts | 457.20 k |
Total calls | 233.00 k |
Total put/call ratio | 2.0 |
Largest owners | Shares | Value |
---|---|---|
EcoR1 Capital | 19.36 mm | $36.60 bn |
Nextech Invest | 12.07 mm | $22.81 bn |
Nextech Crossover I GP S.a r.l. | 12.07 mm | $22.57 mm |
VR Adviser | 11.33 mm | $21.41 bn |
Venrock Healthcare Capital Partners III | 9.68 mm | $12.19 mm |
Bain Capital Life Sciences Investors | 8.66 mm | $16.37 bn |
BlackRock | 8.62 mm | $16.30 bn |
Vanguard | 7.18 mm | $13.57 bn |
Citadel Advisors | 4.41 mm | $8.34 bn |
BBBOF BB Biotech | 4.07 mm | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Dec 24 | EcoR1 Capital | Common Stock | Other | Dispose J | Yes | No | 0 | 8,036,688 | 0.00 | 11,328,000 |
19 Dec 24 | EcoR1 Capital | Pre-Funded Warrants Common Stock | Other | Acquire J | Yes | No | 0.0001 | 8,036,688 | 803.67 | 8,036,688 |
28 Oct 24 | Mohan Bala | Common Stock | Sell | Dispose S | No | Yes | 1.9 | 1,884 | 3.58 k | 54,731 |
25 Oct 24 | Mohan Bala | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,250 | 0.00 | 56,615 |
25 Oct 24 | Mohan Bala | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,250 | 0.00 | 6,250 |
3 Oct 24 | Mandelia Ashish | Common Stock | Sell | Dispose S | No | Yes | 1.96 | 3,361 | 6.59 k | 47,757 |
3 Oct 24 | Brian DeSchuytner | Common Stock | Sell | Dispose S | No | Yes | 1.96 | 5,598 | 10.97 k | 94,824 |
2 Oct 24 | Mandelia Ashish | Common Stock | Sell | Dispose S | No | Yes | 2 | 4,855 | 9.71 k | 51,118 |
2 Oct 24 | Brian DeSchuytner | Common Stock | Sell | Dispose S | No | Yes | 2 | 8,089 | 16.18 k | 100,422 |
1 Oct 24 | Alleva Lawrence M | Stock Option Common Stock | Grant | Acquire A | No | No | 1.83 | 9,615 | 17.60 k | 9,615 |